Artivion Dirección
Dirección controles de criterios 4/4
El CEO de Artivion's es Pat Mackin , nombrado en Sep 2014, tiene una permanencia de 9.58 años. compensación anual total es $3.18M, compuesta por 24.4% salario y 75.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.6% de las acciones de la empresa, por valor de $13.50M. La antigüedad media del equipo directivo y de la junta directiva es de 3.8 años y 7.5 años, respectivamente.
Información clave
Pat Mackin
Chief Executive Officer (CEO)
US$3.2m
Compensación total
Porcentaje del salario del CEO | 24.4% |
Permanencia del CEO | 9.6yrs |
Participación del CEO | 1.6% |
Permanencia media de la dirección | 3.8yrs |
Promedio de permanencia en la Junta Directiva | 7.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Artivion Stock: A First Assessment
Dec 27Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump
Nov 23Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025
Oct 13Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)
Jul 20Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 10Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet
Mar 09Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
Feb 16Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold
Dec 18Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Sep 29Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver
Sep 27Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
Aug 04Is Artivion (NYSE:AORT) Using Too Much Debt?
Jun 27Is Artivion (NYSE:AORT) Using Too Much Debt?
Mar 25CryoLife (NYSE:CRY) Has A Somewhat Strained Balance Sheet
Dec 08CryoLife, Inc. (NYSE:CRY) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 01CryoLife (NYSE:CRY) Takes On Some Risk With Its Use Of Debt
Jul 30Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | US$3m | US$776k | -US$31m |
Sep 30 2023 | n/a | n/a | -US$24m |
Jun 30 2023 | n/a | n/a | -US$28m |
Mar 31 2023 | n/a | n/a | -US$29m |
Dec 31 2022 | US$8m | US$750k | -US$19m |
Sep 30 2022 | n/a | n/a | -US$41m |
Jun 30 2022 | n/a | n/a | -US$17m |
Mar 31 2022 | n/a | n/a | -US$15m |
Dec 31 2021 | US$5m | US$728k | -US$15m |
Sep 30 2021 | n/a | n/a | US$2m |
Jun 30 2021 | n/a | n/a | -US$12m |
Mar 31 2021 | n/a | n/a | -US$13m |
Dec 31 2020 | US$3m | US$606k | -US$17m |
Sep 30 2020 | n/a | n/a | -US$14m |
Jun 30 2020 | n/a | n/a | -US$11m |
Mar 31 2020 | n/a | n/a | -US$5m |
Dec 31 2019 | US$6m | US$689k | US$2m |
Sep 30 2019 | n/a | n/a | US$2m |
Jun 30 2019 | n/a | n/a | US$3m |
Mar 31 2019 | n/a | n/a | US$709k |
Dec 31 2018 | US$3m | US$660k | -US$3m |
Sep 30 2018 | n/a | n/a | -US$5m |
Jun 30 2018 | n/a | n/a | -US$5m |
Mar 31 2018 | n/a | n/a | -US$2m |
Dec 31 2017 | US$3m | US$640k | US$4m |
Compensación vs. Mercado: La compensación total ($USD3.18M) de Pat está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD3.44M).
Compensación vs. Ingresos: La compensación de Pat ha sido consistente con los resultados de la empresa en el último año.
CEO
Pat Mackin (56 yo)
9.6yrs
Permanencia
US$3,176,413
Compensación
Mr. James Patrick Mackin, also known as Pat, has been the Chief Executive Officer and President of Artivion, Inc. (formerly known as CryoLife, Inc.) since September 02, 2014 and has been its Chairman since...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman | 9.6yrs | US$3.18m | 1.6% $ 13.7m | |
Executive VP of Finance | less than a year | US$1.64m | 0.19% $ 1.6m | |
VP & Chief Accounting Officer | 17.7yrs | US$1.06m | 0.33% $ 2.8m | |
Senior VP | 9yrs | US$993.72k | 0.39% $ 3.3m | |
Senior VP & Chief Commercial Officer | less than a year | US$953.41k | 0.38% $ 3.2m | |
VP of Human Resources & Chief Human Resources Officer | 4.7yrs | sin datos | 0.10% $ 895.5k | |
Senior VP of Clinical Research & Chief Medical Officer | 3.1yrs | US$1.61m | 0.20% $ 1.7m | |
Vice President of Research & Development | less than a year | sin datos | 0.032% $ 273.4k | |
Vice President of Global Operations | 3.8yrs | sin datos | 0.062% $ 528.4k |
3.8yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de AORT se considera experimentado (3.8 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman | 9.5yrs | US$3.18m | 1.6% $ 13.7m | |
Independent Director | 7.5yrs | US$217.50k | 0.13% $ 1.2m | |
Independent Director | 20.3yrs | US$230.00k | 0.33% $ 2.8m | |
Independent Director | 2.5yrs | US$217.50k | 0.090% $ 773.0k | |
Independent Director | 20.3yrs | US$235.00k | 0.33% $ 2.8m | |
Independent Presiding Director | 6.6yrs | US$265.00k | 0.099% $ 847.1k | |
Independent Director | 11.9yrs | US$215.00k | 0.28% $ 2.4m | |
Independent Director | 5.8yrs | US$220.00k | 0.087% $ 750.3k | |
Independent Director | 1.5yrs | US$210.00k | 0.045% $ 386.2k |
7.5yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de AORT se considera experimentada (7.5 años de antigüedad promedio).